Valensa in a COVID-19 World

Dear Colleague: Please watch the brief video titled Valensa in a COVID-19 World in which our company addresses how Valensa assures the continuity of your business through comprehensive safety and quality protocols which have been enhanced to address the COVID-19 pandemic.  The video features and interesting conversation between our CEO and one of our production supervisors that […]

Read More »

Valensa Awarded U.S. Patent for Joint Pain Relief

The patent US10,624,919 covers a combination of hyaluronic acid and astaxanthin to alleviate joint deterioration, inflammation, and pain ORLANDO, Fla. (July 8, 2020) — The United States Patent and Trademark Office recently awarded Patent No. 10,624,919 to Florida-based Valensa International for the “Composition and Method to Alleviate Joint Pain Using Low Molecular Weight Hyaluronic Acid […]

Read More »

Prostate Health and a Standardized Lipidosterolic Extract of Saw Palmetto

Prostate Health and a Standardized Lipidosterolic Extract of Saw Palmetto By Margaret H. Dohnalek, PhD, Chief Science Officer, Valensa International Controversy exists regarding whether or not saw palmetto products support prostate health and related lower urinary tract symptoms (LUTS), such as the urge to urinate, frequent urination, and waking up at night to urinate. These […]

Read More »

Latest Science Re-Confirms Anti-inflammatory Role of Zanthin, FlexPro MD

Latest Science Re-Confirms Anti-inflammatory Role of Zanthin, FlexPro MD Valensa’s Science team answered a reporter’s question about inflammation ingredient studies, published between 2000-2020, which have particular impact on healthy aging. Here’s their response: Valensa International continues to be at the forefront of nutraceutical companies by looking at ways to expand our portfolio’s impact on inflammatory […]

Read More »

Spirulina Whitepaper: Activating Immunity

Valensa International presents a new White Paper that outlines how Spirulina, dubbed a “Wonder Food,” supports the innate and acquired immune system’s army of Natural Killers, and adaptive T and B, cells. Published by Parry Nutraceuticals, Valensa’s sister company, the paper includes a comprehensive review of Spirulina’s antibacterial, antiviral and Immuno modulator effects. Read the full […]

Read More »

Study Finds FlexPro MD® Formulation Reduces Joint Pain, Inflammation in Osteoarthritis Model

New Study Validates FlexProMD’s Contribution To Mobility and Quality of Life
Nutrients, a well-respected, peer-review professional journal, published a study that finds ingredients in Valensa’s FlexProMD® reduces joint pain and inflammation in an osteoarthritis-induced model. The study builds on existing research that shows that FlexProMD® is three times more effective at relieving joint discomfort than glucosamine and chondroitin. Ask us how to incorporate this natural formulation into your product line.

Read More »

What USP Means to USPlus® Saw Palmetto and Parry™ Organic Spirulina

A new infographic explains how USP verification builds accountability and trust. The United States Pharmacopeia (USP) helps regulate the dietary supplement industry, which provides a third-party auditing service that reviews, tests and monitors the potency and purity of the brand and related products seeking authenticity. For Valensa International, both the USPlus® Pure Saw Palmetto extract, and […]

Read More »

United States Pharmacopeia Renews Verified Status for First and Only Saw Palmetto for Valensa’s USPlus®

USPlus® Saw Palmetto, which supports prostate health, successfully completes annual surveillance by USP’s Ingredient Verification Program for Dietary Ingredients, reflecting adherence to Good Manufacturing Practices (GMP) and recognized quality standards. ORLANDO, Fla. (April 7, 2020) — Valensa International, a leading provider of Fresh from Florida™ saw palmetto extract, announced today that the company’s USPlus® Saw […]

Read More »

Valensa’s Supply Chain Gives Confidence in Continuity

Valensa’s Integrated Supply Chain Capabilities for Continuity of Your Business For Valensa, the value of investing in a fully integrated supply chain begins with ownership of our astaxanthin production facility in South America and the partnership with our sister company in India for spirulina, chlorella and phycocyanin supply. We go beyond ownership of production to […]

Read More »

Letter from the CEO

RE: Supply Chain Excellence To Count On Dear Wellness Colleague: Like you, we here at Valensa International are focused on the global health issue, and understand your concerns around business disruption. For decades, you’ve trusted us to deliver the highest quality nutraceuticals. I want to assure you that our long-standing commitment to supply chain excellence allows us to sustain production and inventories across our portfolio, even in uncertain times, to support your business […]

Read More »